BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago BioVersys dévoile ses réalisations et ses performances financières pour 2025 Résultats Financiers Essais Cliniques BioVersys Médicaments Antibactériens Financement Des Introductions En Bourse
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Blue Cap AG Reports Successful Financial Year 2025 Blue Cap AG EBITDA Improvement Financial Results 2025 Con-pearl Sale 2026 Forecast
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Blue Cap AG annonce un exercice financier 2025 réussi Amélioration De L'EBITDA Résultats Financiers 2025 Prévisions Pour 2026 Casquette Bleue AG Vente Con-Pearl
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Newron Pharmaceuticals Announces Board Nominee Changes Board Of Directors Annual General Meeting Newron Pharmaceuticals George Garibaldi Paolo Zocchi
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Newron Pharmaceuticals annonce des changements au sein de son conseil d'administration Conseil D'administration Assemblée Générale Annuelle Newron Pharmaceuticals George Garibaldi Paolo Zocchi
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Mersen Reports Resilient 2025 Performance, Projects Growth for 2026 Dividend Proposal Market Expansion 2026 Growth Forecast 2025 Performance Mersen Financial Results
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Performance de Mersen en 2025 et perspectives pour 2026 Investissements Résilience Financière Croissance 2026 Objectifs 2029 Performance 2025
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Groupe GORGE Achieves Strong Financial Performance in 2025 Revenue Growth Financial Performance Order Intake EBITDA Improvement Fundraising Efforts
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Le Groupe GORGE réalise de solides performances financières en 2025 Performance Financière Croissance Des Revenus Amélioration De L'EBITDA Prise De Commande Efforts De Collecte De Fonds
BRIEF published on 03/18/2026 at 07:05, 1 month 16 days ago Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3 FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease
Published on 05/02/2026 at 21:00, 10 hours 20 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 5 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 6 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 7 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 7 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 2 hours 35 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 15 hours 45 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 21:21, 2 days 9 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 2 days 11 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 2 days 11 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 2 days 12 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 2 days 12 hours ago AXA annonce les résultats de son Assemblée Générale
